Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00833365 · ClinicalTrials.gov registry record · NA
Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure
A NA study, sponsored by University of Utah.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00833365 is a NA study that was terminated before completion, run by University of Utah. The registered enrollment target is 15 participants.
The verdict
NCT00833365, a NA study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The primary objective is to evaluate the Patent Ductus Arteriosus (PDA) closure rate of early vs. late use of Ibuprofen (Ibu). The investigators believe that early use of Ibu will have a higher PDA closure rate than later use of Ibu. Early use is defined as medication given before the infant reaches 96 hrs old. Late use is defined as medication given when infant is more than 96 hrs old.
Interventions
- DRUG Ibuprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00833365
The ClinicalTrials.gov registry entry for NCT00833365 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ibuprofen is the first listed.
NCT00833365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00833365 about?
NCT00833365 is a clinical study titled "Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure". The primary objective is to evaluate the Patent Ductus Arteriosus (PDA) closure rate of early vs. late use of Ibuprofen (Ibu). The investigators believe that early use of Ibu will have a higher PDA closure rate than later use of Ibu. Early use is defined as medication given before the infant reaches...
What is the current status of trial NCT00833365?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2009-01. Estimated completion is 2011-11.
What interventions are being tested in trial NCT00833365?
The interventions under investigation include: Ibuprofen (DRUG).
Who is sponsoring clinical trial NCT00833365?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.